Biosafety Level 4 Laboratory

Emerging Infections

DZIF is prepared for emerging infectious diseases. Coronavirus research is being carried out at top speed.

Emerging virus epidemics occur unexpectedly and demand rapid action in order to stop the disease from spreading. The most recent outbreak of SARS-CoV-2 worldwide and the Ebola virus epidemic in West Africa highlight the need for rapid communication to the public and the critical importance of developing diagnostics, vaccines and antiviral drugs as quickly as possible.

The DZIF research field “Emerging Infections” responds to these challenges by getting new vaccine candidates for both Ebola and MERS viruses underway, vaccines against the new coronavirus are developed. The aim now is to accelerate biomedical research on these new coronaviruses and to be prepared for emerging infectious diseases in the future.

Research about "Emerging Infections"


News about the Research Field